
Reata Pharmaceuticals Inc.
RETA | NASDAQ
$172.36
+$0.04 (+0.02%)
At close: Sep 25, 2023, 04:00 PM ET
Market Data
Market Cap $6.57B
Enterprise Value $6.4B
Beta 1.42
Average Volume N/A
Shares Outstanding (Diluted) 41.51M
Shares Change YoY 13.82%
Institutional Ownership N/A
Exchange N/A
ISIN N/A
Price Performance
Price Change 1M N/A
Price Change 3M N/A
Price Change 6M N/A
Price Change YTD N/A
Price Change 1Y N/A
Price Change 3Y N/A
Price Change 5Y N/A
1M CAGR (ann.) 1.8%
1Y CAGR (ann.) 679.2%
5Y CAGR (ann.) 14.5%
All-Time CAGR 42.1%
Valuation
PE Ratio -61.56
Forward PE N/A
PEG Ratio -0.38
Forward PEG -0.38
PS Ratio 269.17
Forward PS N/A
PB Ratio 75.22
P/FCF Ratio -26.32
P/Adj. FCF Ratio -19.47
P/OCF Ratio -30.67
EV/Sales 262.44
EV/EBIT -94.37
EV/EBITDA -62.49
EV/FCF -25.66
Earnings Yield -1.6%
FCF Yield -3.8%
Adj. FCF Yield -5.1%
Financial Health
Net Cash $237.34M
Total Debt $166M
Cash & Short-Term Investments $330.21M
Total Assets $502.59M
Current Ratio 6.75
Quick Ratio 6.75
Debt / Equity Ratio -1.82
Debt / EBITDA -1.62
Debt / FCF -0.67
OCF / Debt -1.50
Interest Coverage -6.47
Altman Z-Score 5.75
Piotroski F-Score 3
Margins & Profitability
Gross Profit Margin 100.0%
Operating Profit Margin -243.8%
EBITDA Margin -12140.1%
Net Profit Margin -14075.0%
FCF Margin -1022.6%
Adj. FCF Margin -1382.7%
SBC / Revenue 2650.3%
SBC Impact (per share) -35.2%
Returns
Return on Assets -60.6%
Return on Equity 47.2%
Return on Invested Capital -59.0%
Return on Capital Employed -59.3%
Return on Tangible Assets -60.6%
Historical Growth (CAGR)
Revenue CAGR 3Y 16.7%
Revenue CAGR 5Y -17.1%
Revenue CAGR 10Y N/A
EPS CAGR 3Y 39.0%
EPS CAGR 5Y 7.2%
EPS CAGR 10Y N/A
FCF CAGR 3Y -20.4%
FCF CAGR 5Y -6.2%
FCF CAGR 10Y N/A
Analyst Forecasts
Analyst Rating Hold
Analyst Count 10
EPS Growth Next 3Y N/A
Revenue Growth Next 3Y N/A
Earnings Date Aug 4, 2024
EPS Estimate (next Q) N/A
EPS Growth Est (next Q) N/A
Revenue Est (next Q) N/A
Revenue Growth Est (next Q) N/A
Fair Value Estimates
Graham Number N/A
Graham Upside N/A
Lynch Fair Value N/A
Lynch Upside N/A
Price Target $62.67
Price Target Upside -63.6%
Cash Flow
Operating Cash Flow $-248.34M
Free Cash Flow $-249.46M
Adj. Free Cash Flow $-337.3M
FCF Per Share -$5.71
OCF Per Share -$5.62
OCF/S Ratio -9217.8%
Income Statement
Revenue $24.4M
Gross Profit $23.55M
Operating Income $-59.48M
EBITDA $-102.46M
Net Income $-80.06M
EPS (Diluted) -$2.80
Revenue / Employee N/A
Profit / Employee N/A
Employees N/A
Add to Watchlist
Select watchlists to add or remove RETA